[HTML][HTML] Nanostructured carrier systems facilitating enhanced delivery of 8-(4-Amino-1 methylbutylamino)-6 methoxyquinoline: a narrative review
GH Abbas - IJS Global Health, 2024 - journals.lww.com
(4-Amino-1-methylbutylamino)-6-methoxyquinoline, an inhibitor of protozoan growth,
presents an opportunity to explore nanostructured drug carriers to overcome these …
presents an opportunity to explore nanostructured drug carriers to overcome these …
[PDF][PDF] Current and emerging trends in antimalarial drugs: a comprehensive review
S Rohilla, A Rohilla, D Kumar - Drug Comb Ther, 2022 - tmrjournals.com
Malaria is a ubiquitous tropical disease which occurs by the bite of malaria parasite of genus
Plasmodium spp. The procurement and treatment of malaria depend on the cost and …
Plasmodium spp. The procurement and treatment of malaria depend on the cost and …
Nanotechnology: Its Usages in Drug Delivery for the Treatment of Human Parasitic Diseases
P Singh, K Niveria, M Yadav, AK Verma - Natural Product Based Drug …, 2023 - Springer
The occurrence of infectious parasitic disease is the leading driver of mortality worldwide.
Treatment of such parasitic disease is challenging due to the minimal target bioavailability of …
Treatment of such parasitic disease is challenging due to the minimal target bioavailability of …
Nanoparticles for antiparasitic drug delivery
Y Sun, D Chen, Y Pan, W Qu, H Hao, X Wang, Z Liu… - Drug Delivery, 2019 - Taylor & Francis
As an emerging novel drug carrier, nanoparticles provide a promising way for effective
treatment of parasitic diseases by overcoming the shortcomings of low bioavailability, poor …
treatment of parasitic diseases by overcoming the shortcomings of low bioavailability, poor …
Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review
Malaria is a life-threatening parasitic disease transmitted by the infected female Anopheles
mosquito. The development of drug tolerance and challenges related to the drugs' …
mosquito. The development of drug tolerance and challenges related to the drugs' …
Nano-targeted drug delivery for parasitic infections
S Sinha, R Sehgal - Emerging Nanomaterials and Nano-Based Drug …, 2022 - Elsevier
Parasitic diseases remain a major public health problem, which affects hundreds of millions
of people especially in developing countries. Most of the available therapies for these …
of people especially in developing countries. Most of the available therapies for these …
Nanosize Carriers for Drug and Vaccine Delivery: Advances and Challenges
Nanomedicine has emerged as a lucrative option, attracting the attention of scientific and
industrial stalwarts for its enormous potential and new business opportunities in the health …
industrial stalwarts for its enormous potential and new business opportunities in the health …
Exploring the potential of antimalarial nanocarriers as a novel therapeutic approach
R Deshmukh - Journal of Molecular Graphics and Modelling, 2023 - Elsevier
Malaria is a life-threatening parasitic disease that affects millions of people worldwide,
especially in developing countries. Despite advances in conventional therapies, drug …
especially in developing countries. Despite advances in conventional therapies, drug …
Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector
P Urbán, E Ranucci, X Fernàndez-Busquets - Nanomedicine, 2015 - Taylor & Francis
Malaria is arguably one of the main medical concerns worldwide because of the numbers of
people affected, the severity of the disease and the complexity of the life cycle of its …
people affected, the severity of the disease and the complexity of the life cycle of its …
Nanocarrier-Assisted Drug Delivery for Neglected Tropical Diseases
Abstract................................................................................................. 449 15.1
Introduction................................................................................ 449 15.2 Overview of Neglected …
Introduction................................................................................ 449 15.2 Overview of Neglected …